Rizvan Bush

698 total citations
16 papers, 484 citations indexed

About

Rizvan Bush is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rizvan Bush has authored 16 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rizvan Bush's work include Lymphoma Diagnosis and Treatment (11 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rizvan Bush is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rizvan Bush collaborates with scholars based in United States, Canada and Switzerland. Rizvan Bush's co-authors include E. Berle, Qinglin Pei, Kara M. Kelly, Cindy L. Schwartz, Kathleen M. McCarten, Peter D. Cole, Sharon M. Castellino, Debra L. Friedman, Frank G. Keller and Monika L. Metzger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Rizvan Bush

16 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rizvan Bush United States 9 244 189 115 113 97 16 484
Jiwon Lim South Korea 16 147 0.6× 65 0.3× 115 1.0× 240 2.1× 185 1.9× 40 630
Magali Verheecke Belgium 12 101 0.4× 93 0.5× 103 0.9× 495 4.4× 67 0.7× 24 792
Anne T. OʼMeara United States 11 175 0.7× 60 0.3× 198 1.7× 236 2.1× 103 1.1× 15 575
H Hagberg Sweden 9 112 0.5× 83 0.4× 24 0.2× 101 0.9× 80 0.8× 14 310
Kyu-Rae Kim South Korea 11 81 0.3× 65 0.3× 140 1.2× 78 0.7× 117 1.2× 22 415
Jonathan A. Cosin United States 15 310 1.3× 28 0.1× 360 3.1× 101 0.9× 237 2.4× 26 686
Angela Thomson United Kingdom 9 700 2.9× 72 0.4× 82 0.7× 226 2.0× 111 1.1× 11 1.2k
Caroline C. Billingsley United States 9 118 0.5× 105 0.6× 173 1.5× 147 1.3× 58 0.6× 26 433
N.R. Abu-Rustum United States 11 410 1.7× 24 0.1× 452 3.9× 181 1.6× 221 2.3× 30 748
Valentin Kolev United States 11 321 1.3× 31 0.2× 227 2.0× 180 1.6× 222 2.3× 38 755

Countries citing papers authored by Rizvan Bush

Since Specialization
Citations

This map shows the geographic impact of Rizvan Bush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizvan Bush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizvan Bush more than expected).

Fields of papers citing papers by Rizvan Bush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rizvan Bush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizvan Bush. The network helps show where Rizvan Bush may publish in the future.

Co-authorship network of co-authors of Rizvan Bush

This figure shows the co-authorship network connecting the top 25 collaborators of Rizvan Bush. A scholar is included among the top collaborators of Rizvan Bush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rizvan Bush. Rizvan Bush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Giulino‐Roth, Lisa, Qinglin Pei, Allen Buxton, et al.. (2020). Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group. Blood. 137(11). 1449–1456. 15 indexed citations
3.
Kelly, Kara M., Peter D. Cole, Qinglin Pei, et al.. (2019). Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group. British Journal of Haematology. 187(1). 39–48. 43 indexed citations
4.
Kahn, Justine M., Kara M. Kelly, Qinglin Pei, et al.. (2019). Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children’s Oncology Group Study. Journal of Clinical Oncology. 37(32). 3009–3017. 30 indexed citations
5.
Castellino, Sharon M., Angie Mae Rodday, Qinglin Pei, et al.. (2019). Performance of FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric Hodgkin lymphoma (HL) patients.. Journal of Clinical Oncology. 37(15_suppl). 10064–10064. 5 indexed citations
6.
7.
Bush, Rizvan, Qinglin Pei, Debra L. Friedman, et al.. (2018). Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1119–1125. 2 indexed citations
8.
Parsons, Susan K., Angie Mae Rodday, Rizvan Bush, et al.. (2018). Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL). Blood. 132(Supplement 1). 3587–3587. 4 indexed citations
9.
Marks, Lianna J., Qinglin Pei, Rizvan Bush, et al.. (2018). Outcomes in intermediate‐risk pediatric lymphocyte‐predominant Hodgkin lymphoma: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 65(12). e27375–e27375. 11 indexed citations
10.
Kahn, Justine M., Kara M. Kelly, Qinglin Pei, et al.. (2018). Survival by age in children and adolescents with Hodgkin lymphoma: A pooled analysis of Children’s Oncology Group (COG) trials.. Journal of Clinical Oncology. 36(15_suppl). 7543–7543. 3 indexed citations
11.
Keller, Frank G., Sharon M. Castellino, Lu Chen, et al.. (2018). Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group. Cancer. 124(15). 3210–3219. 32 indexed citations
12.
13.
Cole, Peter D., Kathleen M. McCarten, Monika L. Metzger, et al.. (2017). Phase 2 trial of brentuximab vedotin and gemcitabine for pediatric and young adult patients with relapsed or refractory Hodgkin lymphoma (HL): A Children’s Oncology Group (COG) report.. Journal of Clinical Oncology. 35(15_suppl). 7527–7527. 4 indexed citations
14.
Berle, E., et al.. (1990). Prognostic factors in patients with stage I epithelial ovarian cancer.. PubMed. 75(2). 263–73. 227 indexed citations
15.
Dembo, A.J., Rizvan Bush, F. A. Beale, et al.. (1984). A randomized clinical trial of moving strip versus open field whole abdominal irradiation in patients with invasive epithelial cancer of the ovary. Gynecologic Oncology. 17(2). 256–256. 26 indexed citations
16.
Sturgeon, Jeremy, Shai Fine, M.K. Gospodarowicz, et al.. (1980). A randomized trial of Melphalan alone versus combination chemotherapy in advanced ovarian cancer. Gynecologic Oncology. 10(3). 368–368. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiwon Lim Breakdown of academic impact, for papers by Magali Verheecke Breakdown of academic impact, for papers by Anne T. OʼMeara Breakdown of academic impact, for papers by H Hagberg Breakdown of academic impact, for papers by Kyu-Rae Kim Breakdown of academic impact, for papers by Jonathan A. Cosin Breakdown of academic impact, for papers by Angela Thomson Breakdown of academic impact, for papers by Caroline C. Billingsley Breakdown of academic impact, for papers by N.R. Abu-Rustum Breakdown of academic impact, for papers by Valentin Kolev
Rankless by CCL
2026